Eleanor M. Scott

1.2k total citations
12 papers, 946 citations indexed

About

Eleanor M. Scott is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Eleanor M. Scott has authored 12 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Eleanor M. Scott's work include Virus-based gene therapy research (9 papers), CAR-T cell therapy research (8 papers) and Cancer Research and Treatments (4 papers). Eleanor M. Scott is often cited by papers focused on Virus-based gene therapy research (9 papers), CAR-T cell therapy research (8 papers) and Cancer Research and Treatments (4 papers). Eleanor M. Scott collaborates with scholars based in United Kingdom, Germany and Malaysia. Eleanor M. Scott's co-authors include Leonard W. Seymour, Jean Rommelaere, Antonio Marchini, Joshua D. Freedman, Margaret R. Duffy, Kerry D. Fisher, Joachim Hagel, Paul Miller, Serena Bonifati and Janet Lei-Rossmann and has published in prestigious journals such as Cancer Research, Gut and Calcified Tissue International.

In The Last Decade

Eleanor M. Scott

12 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eleanor M. Scott United Kingdom 11 547 493 301 191 160 12 946
Hyuk‐Chan Kwon South Korea 11 324 0.6× 661 1.3× 190 0.6× 75 0.4× 116 0.7× 17 1.2k
Magesh Sathaiah United States 11 297 0.5× 393 0.8× 159 0.5× 65 0.3× 134 0.8× 14 794
A.J. Bell United Kingdom 15 125 0.2× 109 0.2× 75 0.2× 87 0.5× 159 1.0× 33 557
Zuqiang Liu China 17 196 0.4× 697 1.4× 219 0.7× 185 1.0× 230 1.4× 38 1.2k
D. Berrebi France 16 334 0.6× 312 0.6× 440 1.5× 317 1.7× 267 1.7× 31 1.2k
Silke Schüle Germany 15 132 0.2× 135 0.3× 198 0.7× 123 0.6× 103 0.6× 43 676
Michelle Millington Australia 11 154 0.3× 141 0.3× 358 1.2× 135 0.7× 377 2.4× 16 941
Ida Ricciardelli United Kingdom 15 288 0.5× 298 0.6× 125 0.4× 493 2.6× 450 2.8× 20 1.3k
A Zander Germany 17 131 0.2× 420 0.9× 317 1.1× 107 0.6× 273 1.7× 51 1.1k
Namrata Setia United States 15 72 0.1× 319 0.6× 124 0.4× 108 0.6× 47 0.3× 67 880

Countries citing papers authored by Eleanor M. Scott

Since Specialization
Citations

This map shows the geographic impact of Eleanor M. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleanor M. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleanor M. Scott more than expected).

Fields of papers citing papers by Eleanor M. Scott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleanor M. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleanor M. Scott. The network helps show where Eleanor M. Scott may publish in the future.

Co-authorship network of co-authors of Eleanor M. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Eleanor M. Scott. A scholar is included among the top collaborators of Eleanor M. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleanor M. Scott. Eleanor M. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Scott, Eleanor M., et al.. (2021). Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy. Journal for ImmunoTherapy of Cancer. 9(4). e001292–e001292. 43 indexed citations
2.
Scott, Eleanor M., et al.. (2019). Use of Liquid Patient Ascites Fluids as a Preclinical Model for Oncolytic Virus Activity. Methods in molecular biology. 2058. 261–270. 7 indexed citations
3.
Scott, Eleanor M., Brian Lyons, Joshua D. Freedman, et al.. (2019). Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples. Journal for ImmunoTherapy of Cancer. 7(1). 320–320. 64 indexed citations
4.
Freedman, Joshua D., Margaret R. Duffy, Janet Lei-Rossmann, et al.. (2018). An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells. Cancer Research. 78(24). 6852–6865. 135 indexed citations
5.
Chia, Suet Lin, et al.. (2018). Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference. Cancer Gene Therapy. 26(3-4). 59–73. 14 indexed citations
6.
Schoeps, Benjamin, et al.. (2018). Antagonism of Glycolysis and Reductive Carboxylation of Glutamine Potentiates Activity of Oncolytic Adenoviruses in Cancer Cells. Cancer Research. 79(2). 331–345. 32 indexed citations
7.
Scott, Eleanor M., Margaret R. Duffy, Joshua D. Freedman, Kerry D. Fisher, & Leonard W. Seymour. (2017). Solid Tumor Immunotherapy with T Cell Engager‐Armed Oncolytic Viruses. Macromolecular Bioscience. 18(1). 60 indexed citations
8.
Freedman, Joshua D., Joachim Hagel, Eleanor M. Scott, et al.. (2017). Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies. EMBO Molecular Medicine. 9(8). 1067–1087. 100 indexed citations
9.
Marchini, Antonio, Eleanor M. Scott, & Jean Rommelaere. (2016). Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade. Viruses. 8(1). 9–9. 84 indexed citations
10.
Marchini, Antonio, Serena Bonifati, Eleanor M. Scott, Assia L. Angelova, & Jean Rommelaere. (2015). Oncolytic parvoviruses: from basic virology to clinical applications. Virology Journal. 12(1). 84 indexed citations
11.
Scott, Eleanor M., et al.. (2000). Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. Gut. 46(suppl 1). I1–I8. 281 indexed citations
12.
Smith, Marie L., et al.. (1989). Effect of etidronate disodium on bone turnover following surgical menopause. Calcified Tissue International. 44(2). 74–79. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026